Q2 2025 · 13F-HR
Propel Bio Management, LLCholdings as filed
Filed 2025-08-13 · accession 0000898432-25-000591
$82.4M
Reported value
16
Positions
2025-06-30
Period end
The Brief · Propel Bio Management, LLC · Q2 2025
AI · grounded in 13F
Propel Bio Management, LLC established a new position in PAGP valued at $24.7M. The fund also initiated new stakes in ACHV for $13.9M and AKRO for $12.2M. Additional new positions include PHAT, ABEO, and APLT. The fund ended the period with 16 positions and total AUM of $82.4M.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 72651A207 | PAGP | PLAINS GP HOLDINGS LP-CL | $24.7M | 30.0% | 1,272,360 | Common | SHARED |
| 004468500 | ACHV | ACHIEVE LIFE SCIENCES INC | $13.9M | 16.9% | 6,153,091 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $12.2M | 14.8% | 228,884 | Common | SHARED |
| 71722W107 | PHAT | PHATHOM PHARMACEUTICALS I | $8.9M | 10.7% | 922,927 | Common | SHARED |
| 00289Y206 | ABEO | ABEONA THERAPEUTICS INC | $5.5M | 6.71% | 974,022 | Common | SHARED |
| 03828A101 | APLT | APPLIED THERAPEUTICS INC | $3.5M | 4.26% | 11,285,420 | Common | SOLE |
| 59935V107 | MIST | MILESTONE PHARMACEUTICALS | $3.5M | 4.22% | 1,791,557 | Common | SHARED |
| 24661P807 | DCTH | DELCATH SYSTEMS INC | $3.1M | 3.73% | 226,052 | Common | SOLE |
| 89854M101 | TCRX | TSCAN THERAPEUTICS INC | $3.0M | 3.67% | 2,087,139 | Common | SHARED |
| 488445206 | ZVRA | ZEVRA THERAPEUTICS INC | $2.0M | 2.48% | 231,874 | Common | SHARED |
| 14070B309 | CAPR | CAPRICOR THERAPEUTICS INC | $695,100 | 0.84% | 70,000 | Common | SHARED |
| F5888J116 | MATPF | MAAT PHARMA SACA | $452,069 | 0.55% | 94,181 | Common | SHARED |
| 04746L104 | — | ATHIRA PHARMA INC | $450,823 | 0.55% | 1,492,792 | Common | SHARED |
| 28249U204 | 72C | EIGER BIOPHARMACEUTICALS | $423,000 | 0.51% | 146,381 | Common | SHARED |
| 004468187 | — | WTS - Achieve Life Sci | $13,687 | 0.02% | 3,699,999 | Common | SHARED |
| 169CVR016 | — | CHINOOK THERAPEUTICS | $2,500 | 0.00% | 79,357 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.